Crypto’s Retail Traders Hit Hard as Strategy ETFs Plunge 80%

Crypto’s downturn — despite greater institutional participation and political support from the Trump White House — has ...

2 Under-the-Radar Stocks to Buy Heading Into 2026

These drugmakers are poised to profit from their innovative engines.

UPay, StraitsX partner to enable frictionless stablecoin spending globally

UPay partners with StraitsX to enable seamless stablecoin spending at 175M Visa merchants, advancing global digital payment ...

Making Sense of Leveraged ETFs: Are They the Right Choice for Long-Term Investors?

Leveraged exchange-traded funds (ETFs), such as ProShares UltraPro QQQ (TQQQ) and ProShares Ultra S&P 500 (SSO) are tempting investment options, but are they the right choice for long-term ...

Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond

Trevi Therapeutics stock (TRVI) earns a Buy rating as Haduvio advances toward phase 3 for chronic cough in IPF. Read the full ...

Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS

Discover why Harrow Inc. (HROW) is a strong buy in 2024—explosive growth from Vevye, rising margins, and a $175 price target.
Forbes

Best Platforms For Day Trading In 2026: Compare Our Top Picks

Capital at risk. The value of your investments can go up and down, and you may get back less than you invest. Day trading involves buying and selling shares over a short period of time, often within a ...